February 20, 2020
Article
Features
Anyone who wants to enroll in a clinical trial should first weigh all the details. Patients should ask key questions like these before signing up.
February 19, 2020
Article
House Call
It’s important to match therapies to goals and fitness when treating older patients diagnosed with cancer.
February 19, 2020
Article
Content
From Neil Peart’s passing following a battle with brain cancer to a new online support group for men with testicular cancer, here’s the news making an impact in the cancer landscape.
February 18, 2020
Article
Letters from Our Readers
We want to know what you think about CURE®! Address your comments to editor@curetoday.com. If you prefer that your comment not be published, please indicate.
February 18, 2020
Article
Editor's Page
PARP Inhibitors are opening new doors in cancer treatment by targeting vulnerabilities in cancer that researchers are beginning to understand better.
February 17, 2020
Article
Features
By taking part in a new survey series, patients with lung cancer can shed light on their quality of life and help drive research.
February 17, 2020
Article
From the Chairman
In the winter issue of CURE ® the cover story deals with how depression affects patients with cancer on their journey, but how it might be a symptom of the disease as well.
February 14, 2020
Article
Features
PARP inhibitors interfere with cancer’s ability to repair damage to its DNA. They are becoming increasingly useful in treating ovarian cancer.
February 14, 2020
Article
Features
In an effort to combat hereditary stomach cancer, it takes the entire family to help understand what it takes.
February 13, 2020
Article
Features
Even after her death from breast cancer, a pediatric nurse continues to help heal children with a book meant to lift their spirits and raise money for their care.
February 13, 2020
Article
Speaking Out
Cancer treatment can take a toll on sexual health, but multiple therapies can help ease these undiscussed side effects. To get help, speak up.
February 12, 2020
Article
Features
Researchers hope the new PROOF trial will show that infigratinib, a targeted drug, will expand options in treating advanced cholangiocarcinoma. Patients are enrolling now.
February 12, 2020
Article
Features
Personal health information isn’t truly private: Medical practices share records and companies sell internet search details. Here’s what patients should know.
February 11, 2020
Article
Features
Cancer and its treatments rob the immune system of power, so it’s imperative that patients get the flu vaccine to stave off illness.